Semaglutide Providers That Take FSA: 5 Verified Picks for 2026
· By the Weight Loss Provider Guide editorial team · How we verify providers
Affiliate disclosure: Some links on this page are affiliate links. We may earn a commission at no extra cost to you. Rankings are determined by verified payment path, documentation support, price transparency, state reach, cancellation friction, and current regulatory standing — not by payout. Several higher-paying providers are demoted or excluded on this page because of verified FDA warning letters or advertising-claims referrals. We'd rather lose the click than send you somewhere your money gets stuck.
The bottom line, first
Eden is the best overall FSA pick for most people — Eden states on its site that you can use an HSA or FSA card for most visits and prescriptions, it offers FDA-approved Wegovy and Zepbound alongside compounded semaglutide at a flat price regardless of dose, ships nationwide, and has avoided the recent FDA warning letters that hit several of its cheaper competitors. Eden's current compounded semaglutide pricing runs $129/first month then $209/month on the 3-month plan, or $149/first month then $229/month on the monthly plan.
That recommendation comes with three honest conditions. If your non-negotiable is seeing the words "HSA or FSA card at checkout" spelled out plainly on a provider's own site before you enter payment info, Willow publishes that wording most directly (with one caveat we disclose below). If you only want FDA-approved semaglutide and an insurance concierge that handles prior authorization, Ro is the cleanest path — get started for $39 the first month, then as low as $74/month with annual plan paid upfront. If your insurance won't touch Wegovy and you still want an FDA-approved brand with a clean reimbursement paper trail, Sesame Care is the fallback.
We checked 10 major telehealth providers, dropped four to a clearly labeled caution lane because of FDA warning letters issued in September 2025 and February 2026, and built the payment-path matrix below.
Quick picks
| If you want… | Go with… | Starting price |
|---|---|---|
| Best overall FSA pick for most people | Eden — compounded + branded, HSA/FSA eligible with all plans, 50 states | $129 first mo / $209 ongoing (3-mo plan); $149 / $229 (monthly) |
| Most explicit "HSA or FSA at checkout" language | Willow — flat price, no dose increase | $299/month all-in |
| FDA-approved Wegovy + insurance concierge | Ro — insurance concierge, submit a detailed receipt after purchase | $39 first month, then as low as $74/mo (annual plan) |
| FDA-approved cash-pay with itemized bill on request | Sesame Care — provider choice, itemized bill on email request | Program from $59/mo (annual) or $99/28 days; medication separate |
| Lowest async entry price (documentation caveat) | Yucca Health — no live visit, fast approval | $146 first month / $206 ongoing (6-month plan) |
What we actually verified
Before we ranked anything, here is the exact work that went into this page. We looked at:
- Each provider's official pricing page, payment FAQ, HSA/FSA-specific page, cancellation/refund terms, and any published guidance on Letters of Medical Necessity
- FDA's warning letter database for every provider on this list
- BBB National Programs / NAD advertising-review decisions from the last 12 months
- IRS Publication 502 and IRS Revenue Procedure 2025-32 (the 2026 FSA contribution limits)
- Public review patterns on Trustpilot and ConsumerAffairs, specifically filtering for payment-path and documentation complaints
What we did not do: we did not test-purchase a subscription at every provider with an FSA card, and we did not call each provider's billing team to verify real-time workflow. A provider's website saying "FSA accepted" doesn't guarantee your specific plan administrator will approve every charge. Verify with your plan before committing.
Next scheduled re-verification: July 2026.
The semaglutide FSA payment-path matrix (verified April 16, 2026)
| Provider | FSA path | Card at checkout? | Itemized receipt? | LMN on request? | State reach | Trust flag |
|---|---|---|---|---|---|---|
| Eden | Direct + reimbursement | ✅ "HSA or FSA card for most visits and prescriptions" | ✅ Yes | ✅ Yes | 50 states | ✅ Clean — no FDA warning letter or NAD referral |
| Willow | Direct + reimbursement | ✅ FAQ states HSA/FSA accepted at checkout | ⚠️ Not as formal policy (supported in practice) | ⚠️ Not as formal policy | ~36 states | ⚠️ NAD referral Dec 4, 2025 (advertising claims — disclosed below) |
| Ro | Reimbursement only | ❌ "We do not accept HSA/FSA cards at this time" | ✅ Detailed receipt post-purchase | ⚠️ Not as formal policy | 50 states | ✅ Clean |
| Sesame Care | Reimbursement via itemized bill | ❌ Medication paid to pharmacy; subscription separate | ✅ Itemized bill on email request | ⚠️ Not as formal policy | 50 states | ✅ Clean |
| Yucca Health | Funds commonly used — documentation gap | ⚠️ Not formally stated | ❌ Does not provide itemized receipts | ❌ Does not provide LMNs | 50 states | ✅ Clean — but documentation gap creates FSA claim risk |
| MEDVi | Direct + reimbursement per support docs | ✅ Yes per support docs | ✅ Yes | ✅ Yes | 49 states | 🚨 FDA warning letter Feb 20, 2026 — moved out of lead |
| SkinnyRX | Direct + reimbursement | ✅ FAQ accepts FSA/HSA | ✅ Yes | ✅ Yes | Most states | 🚨 FDA warning letter Feb 20, 2026 — moved out of lead |
| Hers | Reimbursement-first | ⚠️ Card may require additional steps | ✅ Downloadable | ⚠️ Not as formal policy | 50 states | 🚨 FDA warning letter Sept 9, 2025 — moved out of lead |
| MyStart Health | Direct + reimbursement per stated policy | ✅ Yes per stated policy | ✅ Yes | ✅ Yes | Most states | 🚨 FDA warning letter Sept 9, 2025 — moved out of lead |
"Card at checkout" means the provider's public-facing website states the HSA/FSA card is accepted as a direct payment method. "Reimbursement" means you pay with a personal card, save the itemized receipt, and submit it to your FSA administrator. "Not publicly stated as formal policy" means the behavior may happen in practice but we couldn't locate a written provider policy. Every pricing cell was checked on the provider's own page between April 14 and April 16, 2026.
Pick your path
- Direct card at checkout: Eden or Willow
- FDA-approved + insurance coverage: Ro
- FDA-approved cash-pay with clean reimbursement: Sesame Care
- Lowest async entry price (low-friction FSA plans only): Yucca Health
Eden
Best overall FSA pick for most people
Answer capsule
What you actually get
- Compounded semaglutide — 3-month plan: $129 first month, $209/month ongoing. Flat price at every dose.
- Compounded semaglutide — monthly plan: $149 first month, $229/month ongoing.
- Branded FDA-approved options: Wegovy®, Zepbound®, Ozempic®, and Mounjaro® available on a higher pricing tier.
- FSA/HSA eligibility: Eden states its program is FSA/HSA eligible with all plans and that HSA or FSA cards may be used for most visits and prescriptions.
- Free shipping, 24/7 clinician messaging, community portal.
- 503A compounding pharmacies with third-party testing through FDA and DEA-registered labs.
The one honest tradeoff
Who Eden is best for
- You want one provider for the whole year and the option to move between compounded and brand-name without switching platforms.
- You want predictable pricing so your FSA budget doesn't balloon when your dose steps up.
- You're risk-conscious about compounded GLP-1 providers and want one with no recent FDA warning letter.
Who should skip Eden
- You only want the most explicit "FSA at checkout" wording — see Willow
- You only want FDA-approved semaglutide and your insurance might cover Wegovy — see Ro
- You'd rather pay the lowest monthly entry price with a simple FSA plan — see Yucca
Willow
Most explicit "FSA at checkout" language
Answer capsule
What you get
- Compounded semaglutide injection: $299/month flat, no dose-based increases.
- Compounded tirzepatide injection: also available.
- Direct HSA/FSA card payments welcome per Willow's own FAQ.
- Free assessment with no charge until a clinician reviews your case.
- Typically same-day prescription decisions.
- Cancel anytime by messaging the Patient Care Team.
Willow is currently available in approximately 36 states. State coverage changes periodically, so verify during the free assessment.
The caution label
Documentation note
Who Willow is best for
- Readers who've had an FSA or HSA card declined at another telehealth provider and need maximum payment-path certainty before trying again.
- Anyone who wants flat-price compounded semaglutide through a full dose titration.
- Readers comfortable with compounded-only (no brand-name option through Willow).
Who should skip Willow
- You want the cleanest regulatory record — go to Eden
- You want FDA-approved semaglutide — go to Ro or Sesame
- You live in a state Willow doesn't currently serve — Eden, Ro, Sesame, and Yucca all ship to 50 states.
Ro
Best FDA-approved semaglutide + insurance concierge
Answer capsule
What you get
- Ro Body membership: $39 first month, then as low as $74/month with annual plan paid upfront, or $149/month on the monthly plan.
- FDA-approved medication menu: Wegovy® (semaglutide), Zepbound® (tirzepatide), and Foundayo™ (the FDA-approved oral GLP-1 pill for weight loss).
- Insurance concierge that handles prior authorization paperwork for eligible members.
- Detailed receipt after purchase available for FSA reimbursement.
- 50-state availability.
The payment path in plain English
The honest tradeoff
Who Ro is best for
- You have commercial health insurance and Wegovy might be covered with prior authorization.
- You only want FDA-approved medication — no compounded.
- You're comfortable with a reimbursement workflow and want a detailed receipt for FSA submission.
- You want to try Foundayo, the first FDA-approved oral GLP-1 pill for weight loss.
Sesame Care
Best FDA-approved cash-pay with clean reimbursement
Answer capsule
What you get
- Program pricing: as low as $59/month with annual subscription, or $99 every 28 days month-to-month.
- FDA-approved medication menu including Wegovy® injection, Wegovy® pill (FDA-approved December 2025), Zepbound®, Ozempic®, Mounjaro®, and Rybelsus®.
- Provider choice: unlike most telehealth platforms, you browse and pick your clinician based on experience and reviews.
- Prior authorization help if your insurance covers the medication.
- Itemized bill for HSA/FSA reimbursement available by emailing [email protected].
- Current self-pay pricing: Wegovy pill from $149/month; Wegovy pen $199/month for first two months, then $349/month.
The honest tradeoff
Who Sesame is best for
- You want FDA-approved semaglutide and might have insurance coverage worth exploring.
- You want to try the FDA-approved oral Wegovy pill.
- You want to choose your own provider rather than be assigned one.
- You're comfortable with a reimbursement workflow via emailed itemized bills.
Yucca Health
Lowest-friction async option with documentation caveat
Answer capsule
What you get
- Low entry pricing: $146 first month, then $206/month on the 6-month semaglutide plan.
- Fully async workflow: no live video visit required; licensed provider reviews your intake within 24 hours.
- BNPL options: Klarna, Affirm, and Afterpay available at checkout.
- Fast approval (typically within 24 hours) and UPS 2-Day Air shipping.
- 50-state coverage.
- Strong customer service reviews on public review platforms.
The FSA-specific caveat you need to understand
The card may or may not process at checkout depending on your FSA plan's rules. More importantly, if your plan administrator later asks for an itemized receipt or an LMN to substantiate the expense, Yucca will not generate those for you. If your FSA administrator has ever asked you to substantiate a prior charge, skip Yucca for Eden or Willow — both provide receipts and documentation support.
Who Yucca is best for
- You have a low-friction FSA plan that has never required substantiation.
- You want the lowest entry price for a multi-month commitment.
- You prefer a fully async experience with no live visit.
- You're comfortable with BNPL if you want to spread payments.
Who should skip Yucca
- Your FSA admin has ever asked for documentation on a prior charge — go to Eden
- You want month-to-month with no multi-month commitment — go to Willow
The caution lane: providers we can't lead with right now
MEDVi — FDA warning letter, February 20, 2026
MEDVi is one of the largest compounded GLP-1 telehealth platforms by review volume. HSA/FSA cards work at checkout per support documentation, compounded semaglutide starts at $179 first month / $299/month ongoing, and the company bundles physician access and shipping with no separate membership fee. On February 20, 2026, the FDA issued MEDVi a warning letter (Warning Letter #721455) citing false or misleading claims and misbranding in its marketing of compounded semaglutide and tirzepatide. MEDVi does not manufacture its compounded medications — those are produced by regulated partner pharmacies — but the labeling representations were the basis of the letter.
Who this rules out: readers who prioritize regulatory record. Who might still consider MEDVi: readers who already use it successfully and value the deep menu (branded Wegovy pill, Wegovy injection, and Zepbound injection).
SkinnyRX — FDA warning letter, February 20, 2026
SkinnyRX publishes the single most explicit "we accept HSA/FSA cards" language in its FAQ, offers compounded semaglutide from $199/month in injection, sublingual, and oral tablet formats, and maintains a strong public review profile. On the same day the FDA wrote to MEDVi, it issued SkinnyRX (operated by Lean Rx, Inc.) Warning Letter #717989 citing false or misleading claims and misbranding on skinnyrx.com. The payment path works, but a reader picking the cleanest trust profile goes to Eden instead.
Hers — FDA warning letter, September 9, 2025
Hers is a mainstream brand with strong consumer-facing design. Hers' own page describes its FSA/HSA flow as reimbursement-first — "payment with FSA/HSA card may require additional steps" — with a downloadable receipt for submission. On September 9, 2025, the FDA issued Hims & Hers Health, Inc. (d/b/a Hers) Warning Letter #716825 over compounded semaglutide marketing claims.
MyStart Health — FDA warning letter, September 9, 2025
MyStart Health was cited by other comparison sites for a comprehensive HSA documentation packet — itemized invoice, provider information, prescription details, and proof of payment. But on the same day as Hers, the FDA issued MyStart's CEO a warning letter over compounded GLP-1 marketing claims. Until there's public documentation of resolution, we're not leading readers there.
What this means for you
Does FSA cover the membership fee, or just the medication?
Answer capsule
Provider-by-provider read
- Eden — bundled. Eden's stated pricing includes the doctor's visit, prescription medication, and shipping with no hidden or additional fees, which makes the full program cost straightforward to submit as a medical expense.
- Willow — bundled. Willow's all-inclusive $299/month pricing covers the medication, consultation, and ongoing care.
- Ro — unbundled. Ro's membership is billed separately from medication cost. Both the membership (Ro Body) and the medication are generally medical expenses, but your plan administrator may request documentation for the membership portion because it isn't a pharmacy charge.
- Sesame Care — unbundled. The $59/month (annual) or $99/28-day (monthly) subscription covers ongoing medical care, and medication is separate. Sesame will issue an itemized bill on request that breaks the two out cleanly.
- Yucca Health — bundled into the plan price, but remember Yucca does not issue itemized receipts.
If you want the simplest FSA paperwork, bundled pricing with a provider that issues an itemized receipt (Eden, Willow) creates the fewest questions.
If your FSA card declines at checkout: the 4-step recovery path
Answer capsule
Check your balance and daily transaction limit
Log into your FSA administrator's portal. Verify your available balance is more than the charge you're trying to make. Then check your daily transaction limit — many FSA debit cards cap single transactions, and the limit varies by plan. If the charge is above your limit, call your administrator and ask about a temporary lift, or pay the charge with a personal card and submit for reimbursement instead.
Check whether it's a merchant coding issue
IIAS stands for Inventory Information Approval System — the technology retail pharmacies use to auto-verify that a purchase qualifies as an eligible medical expense. Most online telehealth platforms don't support IIAS the way CVS or Walgreens do, which means your FSA card may decline even though the underlying expense is 100% eligible.
Fix: pay with a personal credit or debit card, save the itemized receipt, and submit a reimbursement claim to your FSA administrator through their portal. Reimbursement windows vary by employer plan — check your plan's run-out period.
If your plan admin emails asking for documentation
Request a Letter of Medical Necessity from your provider's patient portal. Eden, MEDVi, and SkinnyRX have stated policies of issuing LMNs on request; Willow, Ro, and Sesame don't publish formal LMN policies but support documentation in practice — message their care teams and ask. Submit the LMN, the prescription confirmation, and the itemized receipt together through your administrator's portal.
If your administrator specifically mentions weight loss in the denial notice, ask your provider to document the underlying medical reason in the LMN: BMI ≥ 30 for obesity, or BMI ≥ 27 with a weight-related condition (hypertension, high cholesterol, sleep apnea, cardiovascular disease, type 2 diabetes). The ICD-10 code used on the prescription can also strengthen the claim.
If you still get denied, call your administrator directly
Most recurring FSA declines can be resolved with a 10-minute phone call. Ask your plan administrator three specific questions:
- What was the decline reason code on the transaction?
- What documentation will make this charge approve going forward?
- Do I need to pre-authorize this expense category, or is a post-charge receipt sufficient?
Email template you can copy to request an LMN
Subject: Letter of Medical Necessity request — FSA documentation
Hi care team,
My FSA administrator has requested documentation for my semaglutide prescription. Could you send me a Letter of Medical Necessity that includes:
- My name and date of birth
- My diagnosed condition and the ICD-10 code used on the prescription
- A statement that semaglutide is medically necessary for treatment
- The signature of my prescribing provider
Please send it as a PDF to [your email]. Thank you.
Save the response. You'll use it more than once if you continue treatment across multiple plan years.
Can you actually use FSA money for semaglutide? The IRS rule in plain English
Answer capsule
What the IRS actually requires
The IRS defines qualified medical expenses as the "costs of diagnosis, cure, mitigation, treatment, or prevention of disease" (IRS Publication 502). Two things matter for semaglutide:
- There must be a valid prescription from a licensed healthcare provider. Over-the-counter products marketed as "GLP-1 alternatives" do not qualify.
- The prescription must treat a specific disease diagnosed by a physician — not general wellness, not cosmetic weight loss.
The 2026 FSA and HSA limits you need to know
- Health FSA cap: $3,400 for 2026 (per IRS Revenue Procedure 2025-32)
- FSA carryover: up to $680 if your employer offers carryover
- HSA self-only cap: $4,400 for 2026
- HSA family cap: $8,750 for 2026
The practical implication: if you're paying $299/month for compounded semaglutide, that's $3,588 annually — already above the 2026 FSA cap. You can either use the full $3,400 FSA and pay the rest with personal funds, or use an HSA (if you have one) which has the higher cap and rolls over indefinitely.
Letters of Medical Necessity: when you need one and how to get it
Answer capsule
What an LMN must contain to actually work
- Your full name and date of birth
- The diagnosed condition (BMI range and weight-related comorbidity, or diabetes, or the underlying diagnosis)
- The ICD-10 code used on the prescription
- A clear statement that semaglutide is medically necessary for treatment — not for wellness, cosmetic reasons, or general health
- The licensed provider's signature, credentials, and date
Without those five elements, FSA administrators can reject the LMN as insufficient.
How long an LMN stays valid
Most LMNs are good for the plan year in which they were issued. If you're on multi-year semaglutide treatment, plan on requesting a fresh LMN each January if your administrator requires one.
HSA vs FSA differences on LMN requirements
HSAs are more forgiving — a valid prescription alone typically satisfies HSA substantiation, and LMNs are usually only requested if the IRS audits you. FSAs are stricter because the administrator reviews every claim in real time. Diabetes prescriptions usually sail through on a prescription alone; weight-loss-specific prescriptions (branded Wegovy or compounded semaglutide) are more likely to trigger a documentation request.
Compounded vs FDA-approved semaglutide: what actually changes for FSA
Answer capsule
How this affects your FSA workflow
- Tax eligibility: A prescription for a diagnosed condition is what makes the expense qualify. The product's FDA status isn't what the IRS rule turns on.
- FDA product status: FDA-approved medications have been reviewed for safety, effectiveness, and quality. Compounded medications have not. This is a consumer-safety distinction, separate from the tax question.
- Plan administrator friction: compounded prescriptions are somewhat more likely to trigger documentation requests than FDA-approved ones, especially for weight-loss indications.
- Receipt quality: FDA-approved medications filled at a retail pharmacy auto-substantiate cleanly at the pharmacy counter. Compounded medications shipped from a telehealth provider rely on the provider's itemized receipt workflow.
When FDA-approved is worth the extra cost
- You want the cleanest paper trail and least friction with your plan administrator
- You have insurance that might cover Wegovy
- You've already had a compounded GLP-1 claim denied or flagged
- You're risk-averse and the monthly price gap is worth it
When compounded is the reasonable choice
- Your insurance doesn't cover Wegovy at all
- Your FSA admin has successfully processed compounded prescription claims in the past
- You're willing to accept more documentation friction in exchange for a lower monthly cost
The 2026 FSA math: what semaglutide actually costs after tax
Answer capsule
Annual semaglutide cost and after-tax cost by federal bracket
| Monthly price | Annual | 12% bracket | 22% bracket | 32% bracket | Annual FSA savings (22%) |
|---|---|---|---|---|---|
| $149(Eden monthly, first month) | $1,788 | ~$1,573 | ~$1,395 | ~$1,216 | ~$393 |
| $199 | $2,388 | ~$2,101 | ~$1,863 | ~$1,624 | ~$525 |
| $209(Eden 3-mo, ongoing — fits FSA cap) | $2,508 | ~$2,207 | ~$1,956 | ~$1,705 | ~$552 |
| $249 | $2,988 | ~$2,629 | ~$2,331 | ~$2,032 | ~$657 |
| $299(Willow — ~$188 over FSA cap) | $3,588 | ~$3,158 | ~$2,799 | ~$2,440 | ~$789 |
| $349(Wegovy pen self-pay — past FSA cap) | $4,188 | ~$3,685 | ~$3,267 | ~$2,848 | ~$921 |
Simplified federal income tax estimate. Doesn't include FICA savings (additional ~7.65% for payroll-funded FSAs) or state income tax. Actual savings depend on filing status, total taxable income, and state. Not tax advice — consult your plan administrator and tax professional.
HSA vs FSA for semaglutide: the short version
| FSA (2026) | HSA (2026) | |
|---|---|---|
| Contribution cap | $3,400/employee | $4,400 self-only / $8,750 family |
| Rollover | Up to $680 | Unlimited, rolls forever |
| Eligibility | Most W-2 employees | Must have high-deductible health plan |
| Investment growth | No | Yes |
| Best for semaglutide | If balance is about to expire | Long-term (semaglutide is often multi-year) |
If you have both, use the FSA first to burn down any amount at risk of expiring, then use the HSA for the rest. If you only have an FSA and you know you'll be on semaglutide longer than 12 months, consider opening a high-deductible health plan at next open enrollment to add HSA eligibility.
Best semaglutide providers that take FSA, by situation
Answer capsule
- Best overall for most self-pay FSA shoppers: Eden — HSA/FSA eligible with all plans, flat dose pricing, both compounded and FDA-approved options, 50 states, cleanest regulatory record in the top 5.
- Best if you want the most explicit "FSA at checkout" language: Willow — with honest disclosure of the December 2025 NAD referral.
- Best FDA-approved path with possible insurance coverage: Ro — reimbursement workflow, but insurance concierge handles prior authorization.
- Best FDA-approved cash-pay with clean reimbursement: Sesame Care — choose your own provider, itemized bill on request, Wegovy pill from $149/month.
- Best low-entry-price async option (low-friction FSA plans only): Yucca Health — fast async, BNPL available; skip if your FSA admin has ever asked for documentation.
- Best if your insurance has strong Wegovy coverage: Ro — stacks insurance + FSA reimbursement of your copay for the lowest effective cost.
- Best if you specifically want the FDA-approved oral Wegovy pill: Sesame Care or Ro.
Who should skip this page entirely
- Anyone without a diagnosed medical reason for semaglutide — purely aesthetic use is unlikely to be FSA-eligible. Read our BMI eligibility guide first.
- Medicare or Medicaid beneficiaries — these programs rarely cover GLP-1s for weight loss, and you likely don't have an FSA.
- Anyone with a personal or family history of medullary thyroid carcinoma (MTC) or MEN 2 syndrome — semaglutide is contraindicated; talk to your primary care provider first.
- Pregnant, trying to become pregnant, or breastfeeding — semaglutide is not appropriate in any of these states.
How we ranked these providers
Answer capsule
The six factors, in order of weight
- Payment-path clarity — does the provider publicly state whether FSA cards work at checkout? Is the reimbursement workflow documented?
- Documentation support — itemized receipts, Letter of Medical Necessity issuance, ICD-10 coding on receipts.
- Price transparency — are prices clearly shown on product pages, or buried in FAQs? Are there membership fees, hidden upsells, or dose-based price increases?
- State reach — a provider that only serves 36 states can't be the "best" broad pick, however good they are within those states.
- Cancellation friction — notice requirements, non-refundable billing windows, subscription pause options.
- Regulatory signal — recent FDA warning letters and NAD advertising referrals materially lower a provider's ranking.
What we didn't let matter
- Affiliate payout. Several providers on our caution-lane list pay substantially more per acquisition than Eden. They still got moved out of the lead.
- Volume of public reviews alone. Review count without context can reflect acquisition spend as much as satisfaction.
- Brand familiarity. Hers is a household name. That didn't compensate for the September 2025 FDA warning letter on compounded semaglutide claims.
What public reviews tell us
Answer capsule
- Eden — reviewers consistently mention fast approval, flat pricing that doesn't change as dose increases, and individual care-team members by name. Negative reviews cluster around customer service response times during peak periods and auto-renewal surprises.
- Willow — satisfaction on the injectable formulation trends positive; oral tablets and sublingual drops receive noticeably more polarized reviews.
- Ro — reviewers most often cite the insurance-handling process and getting FDA-approved medication at a lower effective cost than cash pay.
- Sesame Care — reviews skew toward provider-choice flexibility and straightforward cash-pay pricing; reimbursement workflow is called out as functional rather than seamless.
- Yucca Health — strong positive reviews specifically on customer-service experience and fast async approval. Less represented in FSA-specific feedback because the documentation gap self-selects customers who don't need paperwork.
Ready to use your FSA on semaglutide?
You've read the matrix, you've seen which providers have which payment path, and you know what your FSA plan probably wants from you. The last step is low-commitment: see current eligibility and pricing at the provider that matches your situation. You're not signing up — you're checking if the path works for you.
Still not sure which semaglutide provider fits your situation?
Every situation is different — your state, your insurance, your FSA plan's substantiation rules, your budget, and whether you want compounded or FDA-approved all matter. If you've read this far and want a faster path to an answer tailored to your specific circumstances, take our 60-second matching quiz. No email required to see your results.
Find my GLP-1 path — free 60-second matching quizFrequently asked questions
Sources and methodology
- IRS Publication 502, Medical and Dental Expenses — eligibility framework for FSA/HSA qualified medical expenses
- IRS Revenue Procedure 2025-32 (October 9, 2025) — 2026 Health FSA contribution and carryover limits
- IRS Publication 969 — HSA, FSA, and HRA plan rules
- FDA Warning Letter to MEDVi, LLC d/b/a MEDVi (#721455), February 20, 2026
- FDA Warning Letter to Lean Rx, Inc. d/b/a SkinnyRX (#717989), February 20, 2026
- FDA Warning Letter to Hims & Hers Health, Inc. d/b/a Hers (#716825), September 9, 2025
- FDA Warning Letter to MyStart Health LLC, September 9, 2025
- FDA press announcement, "FDA warns 30 telehealth companies against illegal marketing of compounded GLP-1s," March 3, 2026
- BBB National Programs / NAD decision on Willow Health, December 4, 2025
- Provider-specific sources (verified April 14–16, 2026): Eden pricing and HSA/FSA policy pages (tryeden.com), Willow FAQ (startwillow.com), Ro FAQ and pricing (ro.co/faq/cost-pricing-services), Sesame Care online weight loss program page (sesamecare.com), Yucca Health FAQ (tryyucca.com)
All pricing and payment-path cells in this guide were verified on provider-hosted pages between April 14 and April 16, 2026. Next scheduled re-verification: July 2026. If you notice a price or policy change we missed, email [email protected] and we'll update within 48 hours.
About this guide. Weight Loss Provider Guide is an independent comparison resource for GLP-1 telehealth providers. We verify pricing, payment workflows, and regulatory standing on a scheduled cadence and publish what we find — including when the biggest providers have the biggest problems. We're paid via affiliate commissions on some links at no extra cost to you. Rankings are determined by evidence and fit, in that order. If a provider pays us more but the evidence points elsewhere, the evidence wins. Always verify your specific plan's rules with your FSA administrator before committing.
Medical disclaimer. This guide is for informational purposes only and is not medical, legal, or tax advice. Always consult a licensed healthcare provider before starting any medication, and confirm FSA/HSA eligibility with your plan administrator before purchase. Semaglutide and other GLP-1 medications carry potential side effects and contraindications, including but not limited to nausea, vomiting, pancreatitis, gallbladder disease, and an FDA boxed warning regarding thyroid C-cell tumors. Do not take semaglutide if you have a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2.